Mathematical modeling of immune response to malaria
疟疾免疫反应的数学模型
基本信息
- 批准号:9238223
- 负责人:
- 金额:$ 31.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-03-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AntigensAttenuatedAutomobile DrivingBloodCD8-Positive T-LymphocytesCD8B1 geneCell CountCellsChildClinicalCommunicable DiseasesCulicidaeDermalDetectionDiscontinuous CapillaryDiseaseDoseEpitopesErythrocytesExposure toGoalsGoldHIV/HCVHepatocyteImageImmune responseImmunityImmunizationInbred BALB C MiceIndividualInfectionInjectableLiverLymphocyte SubsetMalariaMalaria VaccinesMemoryMovementMusNatural ImmunityParasitesParasitic infectionPatternPeripheralPlasmodiumPlasmodium bergheiPlasmodium yoeliiPlayProbabilityProtocols documentationRadiationResearchRoleSimplexvirusSiteSkinSkin TissueSpecificitySpeedSporozoitesStructureSymptomsT-LymphocyteTissuesTravelVaccinesVentVirus DiseasesWalkingWorkbasecell motilitydesignexperimental studyimprovedin vivo imaginginsightintravital imagingkillingsmathematical modelpathogenpreventvaccine candidate
项目摘要
Research Summary
Malaria, a disease caused by parasites of Plasmodium species, remains one of the most relevant infectious dis-
eases; in 2013 over 200 millions of individuals had clinical malaria and over 500,000 individuals, mainly children,
died from it. The infection starts when a Plasmodium-infected mosquito injects into the skin a small dose of sporo-
zoites, a specific form of the parasite, which travel via the blood to the liver, infect hepatocytes, and form liver
stages. Several vaccine candidates, including the most recent RTS,S vaccine, are aimed at eliminating sporo-
zoites from the skin, blood, or hepatocytes. However, the low efficacy of such vaccines highlights the problem
with lack of basic understanding of how Plasmodium sporozoites are eliminated by host immunity. CD8 T cells,
a subset of lymphocytes, have been shown to play an important role in preventing clinical malaria by eliminating
Plasmodium liver stages, specifically in radiation attenuated sporozoites (RAS)-based vaccines. Using intravital
imaging, we have recently discovered that activated CD8 T cells form clusters around Plasmodium-infected hep-
atocytes in mice and that these clusters are important in parasite elimination. Mechanisms driving the formation
of such clusters remain poorly defined and how activated CD8 T cells eliminate liver stages from the whole liver
is not well understood. Another layer of complexity arises as the level of immunity needed for protection depends
on a specific host-parasite combination. By combining mathematical modeling and experiments we will provide
quantitative insights into potential mechanisms that explain contribution of CD8 T cells to elimination of Plasmod-
ium liver stages in mice. We will provide such insights via three complementary specific aims. In specific Aim
1, we will discriminate between alternative mechanisms of formation of CD8 T cell clusters around sporozoite-
infected hepatocytes (T-cell intrinsic vs. T-cell extrinsic), define the role of T cells, specific to irrelevant antigens,
in the formation of clusters, and quantify the impact of T cell cluster size on the efficiency at which liver stages
are eliminated. In specific Aim 2, we will determine the impact of structure of liver sinusoids on the efficiency of
CD8 T search for rare sporozoite-infected hepatocytes and determine the speed at which moving CD8 T cells
can localize the site of infection. Finally, in specific Aim 3 we will discriminate between alternative mechanisms
for a larger number of memory CD8 T cells required for sterilizing protection against exposure to Plasmodium
yoelii sporozoites as compared to Plasmodium berghei sporozoites. Completion of these aims will lead to a better
understanding how CD8 T cells localize and eliminate Plasmodium liver stages from one of the major peripheral
tissues, the liver. This understanding may help in designing more efficient immunization protocols of RAS-based
malaria vaccines. In addition, deeper understanding of the mechanisms by which CD8 T cells eliminate infections
at peripheral sites may be also useful for the improvement of several others CD8 T cell-based vaccines such as
those against HIV, HCV, and HSV.
研究综述
疟疾是一种由疟原虫属寄生虫引起的疾病,仍然是最相关的传染病之一,
病例; 2013年,超过2亿人患有临床疟疾,超过50万人,主要是儿童,
感染开始时,一只感染了疟原虫的蚊子将小剂量的孢子注射到皮肤上,
寄生虫的一种特殊形式,通过血液进入肝脏,感染肝细胞,形成肝脏
阶段几种候选疫苗,包括最新的RTS,S疫苗,旨在消除孢子,
从皮肤、血液或肝细胞中分离出孢子。然而,这种疫苗的低效率突出了这个问题
缺乏对疟原虫子孢子如何被宿主免疫消除的基本理解。CD 8 T细胞,
淋巴细胞的一个子集,已被证明在预防临床疟疾中发挥重要作用,
疟原虫肝脏阶段,特别是基于辐射减毒子孢子(RAS)的疫苗。使用活体内
通过成像,我们最近发现活化的CD 8 T细胞在疟原虫感染的HepG 2细胞周围形成簇,
在小鼠中的寄生虫细胞,这些集群是重要的寄生虫消除。推动形成的机制
这些集群的定义仍然很差,以及活化的CD 8 T细胞如何从整个肝脏中消除肝脏阶段
并没有得到很好的理解。另一层复杂性是,保护所需的免疫水平取决于
特定的宿主-寄生虫组合通过结合数学建模和实验,我们将提供
对解释CD 8 T细胞对消除Plasmod的贡献的潜在机制的定量见解-
小鼠的肝脏阶段。我们将通过三个互补的具体目标提供这些见解。具体目标
1,我们将区分子孢子周围CD 8 T细胞簇形成的替代机制-
感染的肝细胞(T细胞内源性vs. T细胞外源性),定义T细胞的作用,特异性针对不相关抗原,
在集群的形成,并量化T细胞集群的大小对肝脏分期的效率的影响,
都被淘汰了在具体目标2中,我们将确定肝窦结构对
CD 8 T细胞寻找罕见的子孢子感染的肝细胞,并确定移动CD 8 T细胞的速度
可以定位感染部位最后,在具体目标3中,我们将区分替代机制
对于大量的记忆性CD 8 T细胞来说,
约氏疟原虫子孢子与伯氏疟原虫子孢子的比较。这些目标的实现将导致一个更好的
了解CD 8 T细胞如何定位和消除疟原虫肝脏阶段从一个主要的外周血淋巴细胞,
组织肝脏这种理解可能有助于设计更有效的基于RAS的免疫方案。
疟疾疫苗此外,更深入地了解CD 8 T细胞消除感染的机制
也可用于改善其他几种基于CD 8 T细胞的疫苗,
抗HIV、HCV和HSV的药物。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Vitaly V. Ganusov其他文献
The role of models in understanding CD8+ T-cell memory
模型在理解 CD8+T 细胞记忆中的作用
- DOI:
10.1038/nri1550 - 发表时间:
2005-01-20 - 期刊:
- 影响因子:60.900
- 作者:
Rustom Antia;Vitaly V. Ganusov;Rafi Ahmed - 通讯作者:
Rafi Ahmed
Vitaly V. Ganusov的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Vitaly V. Ganusov', 18)}}的其他基金
Mathematical modeling of Mycobacterium tuberculosis dissemination
结核分枝杆菌传播的数学模型
- 批准号:
10364119 - 财政年份:2022
- 资助金额:
$ 31.73万 - 项目类别:
Mathematical modeling of Mycobacterium tuberculosis dissemination
结核分枝杆菌传播的数学模型
- 批准号:
10612718 - 财政年份:2022
- 资助金额:
$ 31.73万 - 项目类别:
相似海外基金
A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
- 批准号:
24K02286 - 财政年份:2024
- 资助金额:
$ 31.73万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
- 批准号:
2420924 - 财政年份:2024
- 资助金额:
$ 31.73万 - 项目类别:
Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
- 批准号:
10596047 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
- 批准号:
10742028 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
- 批准号:
BB/X017540/1 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
- 批准号:
LP210301365 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
- 批准号:
10730832 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
- 批准号:
10659841 - 财政年份:2023
- 资助金额:
$ 31.73万 - 项目类别:
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
- 批准号:
BB/V016067/1 - 财政年份:2022
- 资助金额:
$ 31.73万 - 项目类别:
Research Grant
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
- 批准号:
576545-2022 - 财政年份:2022
- 资助金额:
$ 31.73万 - 项目类别:
Idea to Innovation